Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 66 filings.
24 Aug 2026 1 filing
Rating Action
Long-term cash credit upgraded to AA- (Stable) from A+ (Positive), w.e.f. 24 August 2026.
Unallocated limits upgraded to AA- (Stable) and A1+; long-term upgraded, short-term reaffirmed.
Short-term overdraft reaffirmed at A1+.
Short-term fund-based others reaffirmed at A1+.
Instruments / Ratings
Long term - Fund based - Cash credit: AA- (Stable) from A+ (Positive).
Short term - Fund based - Overdraft: A1+; reaffirmed.
Short term - Fund based - Others: A1+; reaffirmed.
Short term - Non-fund based - Letter of credit: A1+; reaffirmed.
Short term - Non-fund based - Others: A1+; reaffirmed.
Unallocated limits: AA- (Stable) / A1+; upgrade of long-term and reaffirmation of short-term.
Rationale
Acquisition of 53.33% US CrudeChem stake expands scale and diversification.
Consolidation and synergies support revenue ramp and market reach.
Financial risk profile remains strong with negligible debt and robust coverage.
Liquidity position is strong, backed by cash and unutilised limits.
Outlook: Stable; acquisition expected to sustain growth and credit metrics.
Risks: competition, raw-material volatility, forex exposure; mitigants include pass-through and diversification.
FY2026 revenue Rs 772 crore; OPM 17.4%; NPM 16.2%; debt negligible.
Outlook
Change Since Last Rating
Long-term rating upgraded to AA- (Stable) from A+; outlook revised to Stable from Positive.
Financial Highlights
FY2026 consolidated revenue Rs 772 crore; OPM 17.4%; NPM 16.2%; debt negligible.
FY2026 PAT Rs 125 crore.
18 Aug 2026 7 filings
Financial highlights
Standalone revenue from operations: 39,687.83 Lakhs.
Consolidated revenue from operations: 77,222.56 Lakhs.
Standalone PAT: 9,188.96 Lakhs; Consolidated PAT: 12,501.51 Lakhs.
Standalone EPS: 0.80; Consolidated EPS: 1.09.
Final dividend proposed: Rs 0.05 per share; Interim Rs 0.80 already paid.
Record date for final dividend: 04 Sep 2026.
Total equity (Mar 31, 2026): Rs 75,429.50 Lakhs.
Total assets (Mar 31, 2026): Rs 81,786.38 Lakhs.
Consolidated total assets: Rs 115,921.65 Lakhs.
Net debt to equity (consolidated): -0.03x (net cash).
Operations & expansion
FY2025-26 production: 81,731 MT; previous year: 60,692.40 MT.
Sales volume: 80,356.73 MT.
Ambernath facility commissioned; capacity added 15,000 MT.
Acquired 53.33% stake in CrudeChem Technologies LLC (Dec 2025).
Product portfolio expands to over 470 specialty products.
Capital, dividends & shareholding
Share capital increased to Rs 11,645.01 Lakhs; 1,16,45,00,900 shares (post-split).
Bonus issue: 4:1; stock split approved Oct 2025.
Warrants converted into 18,75,000 shares; further conversions increased equity base.
Promoters hold 58.88% of equity; other major holders disclosed in notes.
ESG & sustainability
Energy intensity: 4.60 GJ per Rs crore; water intensity: 126.18 KL per Rs crore.
Renewable energy use: 94,716 kWh; Ambernath rooftop solar.
CSR spend: Rs 118.75 Lakhs; workforce 300; women 20.56% of permanent staff.
Zero workplace accidents in FY2025-26.
ESG credentials: ZDHC, NABL, GreenPro; EcoVadis Commitment Badge; US EPA approvals.
Great Place to Work certification achieved; multiple governance credentials.
Governance & key changes
Board size: 7; Independent Directors: 4 including one woman; two women on board.
Chetan Navinchandra Shah appointed Independent Director Aug 12, 2025.
Navin Mittal ceased as Independent Director Sep 27, 2025.
Audit Committee: 4 members; 6 meetings conducted in FY2025-26.
Secretarial Audit by HSPN & Associates; annual secretarial compliance reported.
Related Party Transaction policy: arm's length, up to ₹500 crore; Schedules disclosed.
Strategy & outlook
Strategic growth through India-Malaysia-USA platform; expand across textile, water treatment, cleaning, oilfield chem.
Intensified R&D and application-led product development; cross-market technology transfer.
Pursue selective inorganic growth to enhance technology, customers, and geographic reach.
Maintain disciplined capital allocation; expand renewable energy adoption and governance frameworks.
Subsidiaries & acquisitions
Subsidiaries include FSPL, Manya Manufacturing, Finoclean, Fineotex Malaysia, and CCT group (Dubai/USA).
CrudeChem acquisition broadened North American oilfield platform; multiple US entities integrated as step-down subsidiaries.
BT Chemicals SDN BHD and related Malaysian units remain major group entities with strong ties.
Risks & regulatory environment
Exposure to raw material price volatility, FX fluctuations, and regulatory changes.
Geopolitical and supply-chain disruptions could affect demand in certain markets.
Ongoing focus on compliance with SEBI LODR, ICDR, and corporate governance standards.
AGM Details
AGM on Friday, 11 September 2026 at 04:00 PM IST via VC/OAVM.
Record date for voting: 04 September 2026.
Remote e-voting period: 08-10 September 2026.
Dividend
Interim dividend already declared: Rs 0.80 per equity share.
Final dividend proposed: Rs 0.05 per equity share.
Record date for final dividend: 04 September 2026.
Payment by 30 September 2026, subject to tax deduction.
Resolutions
Ordinary: Adopt Audited Standalone and Consolidated Financial Statements for FY2025-26.
Ordinary: Confirm interim dividend and declare final dividend of Rs 0.05 per share.
Ordinary: Re-appoint Aarti Mitesh Jhunjhunwala as director.
Ordinary: Ratify remuneration of Cost Auditor Rs 50,000 plus taxes.
Special: Raise funds via issuance of equity or other securities up to ₹800 crore.
Special: Approve material related party transactions with FZE and CCT up to ₹500 crore.
Material Related Party Transactions
RPTs between FZE and CCT up to ₹500 crore for FY2026-27, arm's length.
RPTs include sale, purchase, services and loans; defined as material.
Counterparties: Fineotex Biotex HealthGuard FZE and CrudeChem Technology LLC.
Directors / Cost Auditor
Re-appointment of Mrs Aarti Mitesh Jhunjhunwala as director (DIN 07759722).
Remuneration of Cost Auditor ratified: Rs 50,000 per annum plus taxes.
Overview
Standalone BRSR for FY2025-26 covering Apr 1, 2025 to Mar 31, 2026.
Manufactures specialty chemicals; 100% turnover from textile, oil & gas, hygiene and cleaning.
Six plants and one office in India; one international office; 14 states, 70 countries; exports ~15.3%.
CSR applicability Yes; CSR turnover ₹39,687.83 Lakhs; net worth ₹75,429.50 Lakhs.
Assurance: Standalone; not applicable.
Key ESG Risks & Opportunities
Occupational health and safety: risk; mitigated by ISO 45001 and safety teams; negative financial implications.
Water management: risk; reuse of rinse water and STP treatment; negative financial implications.
Hazardous products: opportunity; GHS classification drives safer products; no disclosed financial impact.
Sustainable product development and procurement: opportunity; lifecycle management and renewable materials.
Social accountability: opportunity; code of conduct for stakeholders enhances ethics and trust.
Governance and ethics: opportunity; anti-corruption and whistleblower policy strengthen governance.
Cybersecurity and data privacy: risk; ISO 27001 and policy mitigate; potential negative impact.
Risk management: positive; dedicated risk management committee oversees risks and mitigation.
Governance & Policy Highlights
Administrative Committee is highest authority for BR policy implementation and ESG oversight.
Board-approved policies cover anti-bribery, whistleblower, human rights, and ESG governance.
Anti-bribery policy in place; link: https://fineotex.com/wp-content/uploads/2023/08/Anti-Bribery-and-Anti-CorruptionPolicy.pdf
Whistleblower and Code of Conduct; annual conflict declarations by directors.
Assurance: Not Applicable; zero fines/penalties in FY2025-26.
Social Responsibility & Workforce
Total workforce: 120 permanent employees and 180 workers.
Board female representation: 2 of 7 directors (28.6%).
Turnover FY2025-26: permanent employees 4.25%; workers 1%.
Well-being expenditure: 6.05% of revenue on well-being measures.
LTIFR: 0 for both employees and workers.
100% training coverage across board, KMP, employees, and workers.
Grievance mechanisms: SCORES portal; investor email; plant grievance box.
Human rights policy and ICC for sexual harassment; RPwD Act compliant; equal opportunity policy.
Gross wages for females as share of total: 15.93%.
Parental leave return-to-work/retention: 0% across categories.
Premises accessible to differently abled; RPwD Act compliant.
Environmental Performance
Total energy: 1,827.41 GJ; renewables 340.98 GJ; non-renewables 1,486.44 GJ.
Energy intensity: 4.60 GJ per crore turnover; PPP-adjusted 93.65.
Water withdrawals/consumption: 50,080 KL; no water discharge reported.
Water intensity: 126.18 KL per crore turnover; 2566.60 KL per USD PPP.
GHG: Scope 1 162.36 tCO2e; Scope 2 330.32 tCO2e; total 492.68 tCO2e.
Emission intensity: 1.24 MT/Cr turnover; 0.0134 MT/MT goods.
Waste: plastic 56 MT; total waste 149 MT; 56 MT reused; 93 MT disposed.
Zero-liquid-discharge: treated water reused for gardening.
Certifications: ISO 14001, ISO 9001, ISO 45001, ISO 27001; SA8000; NABL labs.
Solar rooftop: 100 kW at Ambernath plant since Sep 2023.
EPR compliance: CPCB registrations and waste collection plans submitted.
Stakeholder Engagement & Complaints
Key stakeholder groups: suppliers, customers, investors, employees/workers, financial institutions, community.
Engagement methods: emails, meetings, events, surveys; frequency varies (continuous/annual).
Grievances FY2025-26: zero complaints filed; zero pending resolutions.
Grievance mechanisms: SCORES portal; investor email; plant grievance box.
ESG policy available on company website.
Other Notable Metrics
Sustainable sourcing: ~90% of inputs sourced sustainably.
NABL-accredited labs support testing and product development.
No product recalls in FY2025-26.
Data privacy: ISO 27001; no data breaches reported.
Value chain assessments: 45% of partners assessed for health and safety practices.
EPR compliance: CPCB registrations and waste collection plans filed.
Financial performance
Standalone revenue ₹39,687.83 Lakhs; down vs ₹43,922.21 FY24-25
Standalone PAT ₹9,188.96 Lakhs; decline vs ₹9,722.67
Consolidated revenue ₹77,222.56 Lakhs; up from ₹53,333.28
Consolidated PAT ₹12,501.51 Lakhs; up 14.5% YoY
Consolidated EPS ₹1.09; Standalone EPS ₹0.80
EBITDA (Consolidated) ₹16,781.93 Lakhs
ICRA reaffirmed long-term A+ Positive; short-term A1+
Interim dividend ₹0.80 per share; final ₹0.05 proposed for FY26
Operational performance and capacity
Ambernath facility commissioned; first phase adds 15,000 MT annually
Consolidated production 81,731 MT; sales 80,356.73 MT FY2025-26
CrudeChem Technologies Group acquired 53.33% stake; US oilfield platform
Record date for final dividend 04-Sep-2026; approval at AGM pending
Capital structure and dividends
Total equity (Consolidated) ₹93,972.95 Lakhs; Standalone ₹75,429.50 Lakhs
Equity share capital increased to ₹11,645.01 Lakhs; 11,645,00,900 shares
Bonus issue 91,66,00,720 shares; stock split; record date 31 Oct 2025
Warrant conversions: 1,37,50,000 and 50,00,000 shares; 18,75,000 warrants converted
Final dividend proposed ₹582.25 Lakhs; ₹0.05 per share
Cash flows and liquidity
Consolidated cash flow from operations: negative ₹2,380.88 Lakhs
Investing cash flow: ₹10,517.59 Lakhs; Financing: ₹-6,251.58 Lakhs
Net cash from year: ₹2,720.44 Lakhs; closing cash ₹5,611.79 Lakhs
ESG and sustainability
ESG at a glance: low carbon 0.55 μg/m3; water intensity 126.18 KL per crore
Renewable energy consumption 94,716 kWh; Great Place to Work certified
CSR spend ₹118.75 Lakhs; unspent ₹168.80 Lakhs carried to CSR account
Governance and risk
Board: 7 directors; 4 Independent; 2 women; KMPs aligned to governance
ICRA reaffirmation; governance framework with risk management and internal controls
Auditors: ASL & Co. re-appointed; Secretarial: HSPN & Associates; Cost Auditor: V J Talati
Strategic developments
CrudeChem acquisition expands high-value oilfield chemicals platform
Ambernath expansion supports broader multi-vertical chemicals growth
AGM Details
AGM date/time: 11 September 2026 at 04:00 PM IST via VC/OAVM.
Record date for voting eligibility: 04 September 2026.
Remote e-voting: 08–10 September 2026, 09:00–17:00 IST.
AGM conducted via VC/OAVM; deemed venue is the registered office.
Resolutions proposed
Ordinary: Adopt standalone and consolidated financial statements for year ended 31 March 2026.
Ordinary: Confirm interim dividend and declare final dividend for 2025-26.
Ordinary: Re-appoint Mrs. Aarti Mitesh Jhunjhunwala as director.
Ordinary: Ratify cost auditor remuneration of Rs 50,000 per annum for FY2026-27.
Special: Approve fund-raising by issuing securities up to ₹800 crore.
Special: Approve related party transactions with FZE and CCT up to ₹500 crore.
Dividend
Interim dividend of Rs 0.80 per equity share already paid.
Final dividend of Rs 0.05 per share proposed for FY2025-26.
Record date fixed for final dividend: 04 September 2026.
Payment by 30 September 2026 subject to tax deduction at source.
Directors
Re-appoint Mrs. Aarti Mitesh Jhunjhunwala as Director (DIN 07759722).
Remuneration last drawn in 2025-26: Rs 1.07 crore.
Board attendance in 2025-26: 7 of 7 meetings.
Auditors
Cost Auditor remuneration ratified: Rs 50,000 per annum for FY2026-27.
Material Related Party Transactions
Counterparties: Fineotex Biotex HealthGuard FZE and CrudeChem Technology LLC.
Nature: sale/purchase of goods or services; loans and advances.
Aggregate value: up to ₹500 crore for FY2026-27.
Pricing: arm's-length; TNMM.
Capital raising / Other approvals
Board-approved enabling resolution to issue Securities up to ₹800 crore.
Pricing floor not less than ICDR floor price; discount up to 5%.
Completion window: 365 days from resolution passing.
No single allottee >50% of issue size; MF minimum 10%.
Record date and AGM details
Purpose: set cut-off date for remote e-voting and record date for final dividend.
Security: Equity shares.
Record date and cut-off date: September 04, 2026.
AGM date and mode: September 11, 2026 at 04:00 PM IST via VC/OAVM.
Dividend payment details: amount not specified; final dividend subject to AGM approval.